menu
    • menu

    Company profile for Aptar Pharma

    NEW Drugs in Dev: 3
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Aptar Pharma, we have been setting the standard for the drug delivery industry for decades and continue to break new ground in innovative healthcare technologies.Trusted partner of the pharmaceutical community, we provide a large range of specialized drug delivery devices, components and services, enabling the success of our clients. We simplify and accelerate our partners’ path through approval and compliance processes. ...
    At Aptar Pharma, we have been setting the standard for the drug delivery industry for decades and continue to break new ground in innovative healthcare technologies.Trusted partner of the pharmaceutical community, we provide a large range of specialized drug delivery devices, components and services, enabling the success of our clients. We simplify and accelerate our partners’ path through approval and compliance processes. We harness healthcare trends to continuously offer innovative, convenient and safe products for all customers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aptar PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    265 Exchange Dr Crystal Lake, Illinois 60014
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aptar.com/pharmaceutical/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aptargroup-inc-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/aptar?ref

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aptar Pharma Advances Multi-Year FDA-Funded Research Deal
    Aptar Pharma Advances Multi-Year FDA-Funded Research Deal

    07 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-07/aptar-pharma-announces-progress-on-multi-year-us-fda-funded-research-contract

    PHARMIWEB
    07 May 2026
    Share Share
    Aptar Unidose System Used In ENA Respiratory Ph II Study
    Aptar Unidose System Used In ENA Respiratory Ph II Study

    19 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260319657698/en/Aptars-Unidose-Powder-Nasal-Delivery-System-Used-in-ENA-Respiratory-Phase-II-Clinical-Study-of-Investigational-INNA051-Nasal-Spray

    BUSSINESSWIRE
    19 Mar 2026
    Share Share
    Aptar Pharma And COVIRIX Medical Partner To Develop Inhalable
    Aptar Pharma And COVIRIX Medical Partner To Develop Inhalable

    12 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260312429739/en/Aptar-Pharma-and-COVIRIX-Medical-Partner-to-Develop-Inhalable-Antiviral-Treatments

    BUSSINESSWIRE
    12 Mar 2026
    Share Share
    Aptar To Participate In Upcoming Investor Conferences
    Aptar To Participate In Upcoming Investor Conferences

    18 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260218305991/en/Aptar-to-Participate-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    18 Feb 2026
    Share Share
    Aptar Reports Fourth Quarter And Annual 2025 Results
    Aptar Reports Fourth Quarter And Annual 2025 Results

    06 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-06/aptar-reports-fourth-quarter-and-annual-2025-results

    PHARMIWEB
    06 Feb 2026
    Share Share
    Aptar Nasal Delivery Used in CastleVax Ph II COVID Vaccine Trial
    Aptar Nasal Delivery Used in CastleVax Ph II COVID Vaccine Trial

    13 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260113832919/en/Aptars-Nasal-Vaccine-Delivery-Solutions-Featured-in-CastleVax-Phase-II-Clinical-Trial-of-an-Intranasal-COVID-19-Vaccine-Candidate

    BUSINESSWIRE
    13 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search